Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
W
wired.com@web.brid.gy
@wired.com@web.brid.gy
Posts
-
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments -
The Ancient Art of Nasal Rinsing Might Protect You From a ColdNew research has given credence to a 5,000-year-old practice.